{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Virios Therapeutics, Inc.
Is Virios Therapeutics, Inc. technically bullish or bearish?
As of June 20, 2025, Virios Therapeutics, Inc. exhibits a bearish technical trend, supported by a bearish weekly MACD, Bollinger Bands, and a mildly bearish KST, despite some conflicting signals from daily moving averages.
What does Virios Therapeutics, Inc. do?
Virios Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $11 million and a market cap of $9.14 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -132.82%.
How big is Virios Therapeutics, Inc.?
As of Jun 18, Virios Therapeutics, Inc. has a market capitalization of 9.14 million and reported net sales of 0.00 million with a net profit of -21.98 million over the latest four quarters. Shareholder's funds are at -10.12 million, while total assets amount to 101.21 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
